Wes Pharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WES PHARMA INC, and what generic and branded alternatives to WES PHARMA INC drugs are available?
WES PHARMA INC has five approved drugs.
Drugs and US Patents for Wes Pharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wes Pharma Inc | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 207509-001 | Oct 29, 2018 | AA | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Wes Pharma Inc | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | buprenorphine hydrochloride; naloxone hydrochloride | TABLET;SUBLINGUAL | 209069-002 | Jul 17, 2020 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Wes Pharma Inc | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 210211-001 | Oct 30, 2017 | AA | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.